UROD Antibodies

Santa Cruz Biotechnology features a diverse variety of UROD monoclonal antibodies for investigating uroporphyrinogen decarboxylase (UROD) in various biological processes. UROD monoclonal antibodies are compatible with multiple research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UROD is a key enzyme in the heme biosynthesis pathway, catalyzing the conversion of uroporphyrinogen to coproporphyrinogen. UROD maintains cellular homeostasis and is essential for the proper functioning of hemoglobin and other heme-containing proteins. Mutations or deficiencies in UROD can lead to porphyrias, a group of disorders characterized by the accumulation of porphyrins, which can have significant clinical implications. Understanding UROD function and regulation provides crucial insights into metabolic pathways and disease mechanisms. Research utilizing UROD monoclonal antibodies helps elucidate the molecular basis of porphyrias and related disorders. Investigating UROD expression patterns and interactions advances knowledge of heme metabolism and associated diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to understanding metabolic disorders and developing potential therapeutic strategies.